LOPE vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 01, 2026

LOPE

49.7
AI Score
VS
LOPE Wins

UTI

46.2
AI Score

Investment Advisor Scores

LOPE

50score
Recommendation
BUY

UTI

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric LOPE UTI Winner
Forward P/E 13.2979 27.248 LOPE
PEG Ratio 0.8865 1.8142 LOPE
Revenue Growth 6.7% 7.2% UTI
Earnings Growth 18.2% -78.9% LOPE
Tradestie Score 49.7/100 46.2/100 LOPE
Profit Margin 19.6% 3.9% LOPE
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD LOPE

Relative Price Performance (Last 90 Days)

LOPE 1M: +2.4% · 3M: +0.7% UTI 1M: -8.7% · 3M: -60.6%

Current Technical Phase

LOPE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.4% over 20 days), RSI 58

RSI (14): 57.8 · Price: $153.71

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -26.6%), weak momentum, RSI 32

RSI (14): 31.7 · Price: $19.03

Fundamentals Snapshot

Metric LOPE UTI
Market Cap — —
Forward P/E 13.6 25.9
Trailing P/E 18.3 30.6
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.0%
EPS 8.28 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, LOPE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.